Search Results - "Gröchenig, H. P."

The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis by Kump, P., Wurm, P., Gröchenig, H. P., Wenzl, H., Petritsch, W., Halwachs, B., Wagner, M., Stadlbauer, V., Eherer, A., Hoffmann, K. M., Deutschmann, A., Reicht, G., Reiter, L., Slawitsch, P., Gorkiewicz, G., Högenauer, C.

“…Summary Background Faecal microbiota transplantation is an experimental approach for the treatment of patients with ulcerative colitis. Although there is…”
Get full text

P331 Real-world assessment of biological treatment of inflammatory bowel disease at an Austrian Referral Centre: the ULTIMATE study by Gröchenig, H P, Walter, E, Redl, A, Bresztowanszky, M, Steidl, K, Siebert, F, Novacek, G

“…Abstract Background Inflammatory bowel diseases (IBD) are characterised by a chronic or relapsing inflammation of affected gut segments leading to progressive…”
Get full text

P594 Predictors of non-response to repeated faecal microbiota transplantation in patients with therapy refractory ulcerative colitis by Blesl, A, Rainer, F, Wurm, P, Durdevic, M, Petritsch, W, Wenzl, H, Baumann-Durchschein, F, Posch, A, Streit, A, Gorkiewicz, G, Gröchenig, H-P, Kump, P, Högenauer, C

“…Abstract Background Double-blind randomised studies investigating faecal microbiota transplantation (FMT) in chronic active ulcerative colitis (UC) have shown…”
Get full text

P308 The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease by Kutschera, M, Waldhör, T, Gröchenig, H P, Haas, T, Wenzl, H, Steiner, P, Koch, R, Feichtenschlager, T, Eckhardt, G, Mayer, A, Kirchgatterer, A, Ludwiczek, O, Platzer, R, Papay, P, Gartner, J, Fuchssteiner, H, Peters, P G, Reicht, G, Moser, G, Dejaco, C, Primas, C, Novacek, G, Miehsler, W

“…Abstract Background inflammatory bowel diseases (IBD) are lifelong conditions challenging the patient not only with respect to somatic complaints but also…”
Get full text

A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium by Lenti, M.V., Ribaldone, D.G., Borrelli de Andreis, F., Vernero, M., Barberio, B., De Ruvo, M., Savarino, E.V., Kav, T., Blesl, A., Franzoi, M., Gröchenig, H.P., Pugliese, D., Ianiro, G., Porcari, S., Cammarota, G., Gasbarrini, A., Spagnuolo, R., Ellul, P., Foteinogiannopoulou, K., Koutroubakis, I., Argyriou, K., Cappello, M., Jauregui-Amezaga, A., Demarzo, M.G., Silvestris, N., Armuzzi, A., Sottotetti, F., Bertani, L., Festa, S., Eder, P., Pedrazzoli, P., Lasagna, A., Vanoli, A., Gambini, G., Santacroce, G., Rossi, C.M., Delliponti, M., Klersy, C., Corazza, G.R., Di Sabatino, A., Mengoli, C., Aronico, N., Lepore, F., Broglio, G., Merli, S., Natalello, G., Alimenti, E., Scalvini, D., Muscarella, S., Agustoni, F., Pagani, A., Chiellino, S., Corallo, S., Musella, V., Cannizzaro, R., Vecchi, M., Caprioli, F., Gabbiadini, R., Dal Buono, A., Premoli, A., Locati, L.D., Buda, A., Contaldo, A., Schiepatti, A., Biagi, F., Morano, D., Cucè, M., Kotsakis, A., De Lisi, G.

“…Data regarding the clinical outcome of patients with immune checkpoint inhibitor (ICI)-induced colitis are scant. We aimed to describe the 12-month clinical…”
Get full text

P352 Is diagnostic delay associated with the risk of colectomy in patients with ulcerative colitis? Results of a study of the Austrian IBD study group by Novacek, G, Gröchenig, H P, Haas, T, Wenzl, H, Steiner, P, Koch, R, Feichtenschlager, T, Eckhardt, G, Mayer, A, Kirchgatterer, A, Ludwiczek, O, Platzer, R, Papay, P, Gartner, J, Fuchssteiner, H, Miehsler, W, Peters, P, Reicht, G, Vogelsang, H, Dejaco, C, Waldhör, T

“…Abstract Background Long diagnostic delay is frequent in inflammatory bowel disease and has been described to be associated with an increased risk for…”
Get full text

Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH by Fuchssteiner, H, Nigl, K, Mayer, A, Kristensen, B, Platzer, R, Brunner, B, Weiß, I, Haas, T, Benedikt, M, Gröchenig, H P, Eisenberger, A, Hillebrand, P, Reinisch, W, Vogelsang, H

“…This is a consensus of the Austrian working group of IBD (inflammatory bowel diseases) of the ÖGGH on nutrition in IBD. Malnutrition should be assessed in case…”
Get more information

P364 Successful improvement of dysbiosis by fecal microbiota transplantation is not sufficient to induce clinical remission in chronic active ulcerative colitis by Kump, P.K., Gröchenig, H.-P., Lackner, S., Trajanovski, S., Reicht, G., Hoffmann, K.M., Wenzl, H.H., Petritsch, W., Gorkiewicz, G., Hoegenauer, C.

Get full text

Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology by Angelberger, S, Campregher, C, Fuchssteiner, H, Gasche, C, Gröchenig, H-P, Haas, T, Kazemi-Shirazi, L, Mayer, A, Miehsler, W, Platzer, R, Reinisch, W, Steiner, P, Tilg, H, Tillinger, W, Vogelsang, H, Novacek, G

“…Patients with ulcerative colitis and Crohn's colitis are at increased risk of colorectal cancer (CRC). This risk is dependent on the duration and extent of…”
Get more information

Recommendations for the use of faecal microbiota transplantation "stool transplantation": consensus of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society of Infectious Diseases and Tropical Medicine by Kump, P K, Krause, R, Steininger, C, Gröchenig, H P, Moschen, A, Madl, C, Novacek, G, Allerberger, F, Högenauer, C

“…The intestinal microbiota has a pivotal role in the maintenance of health of the human organism, especially in the defense against pathogenic microorganisms…”
Get more information

In Process Citation by Novacek, G, Dejaco, C, Gröchenig, H P, Högenauer, C, Knoflach, P, Miehsler, W, Moschen, A, Petritsch, W, Vogelsang, H, Tilg, H

Get more information